No Data
No Data
The actual controller of Chinese Health (301408.SZ) pledges 28 million shares
Chinese Health (301408.SZ) announced that He Jiale, the controlling shareholder and actual controller of the company, held 280...
Anhui Huaren Health Pharmaceutical: Anhui Chinese Health Pharmaceutical Co., Ltd. 2023 Annual Report (updated)
Anhui Huaren Health Pharmaceutical's (SZSE:301408) Problems Go Beyond Weak Profit
Anhui Huaren Health Pharmaceutical Co., Ltd.'s (SZSE:301408) stock showed strength, with investors undeterred by its weak earnings report. We think that shareholders might be missing some concerning
Chinese Health (301408.SZ) announced its 2023 annual results, with net profit of 115 million yuan, a decrease of 28.68%
Chinese Health (301408.SZ) released its 2023 annual report. During the reporting period, the company achieved operating income of 3...
Chinese Health (301408.SZ): Anhui Guosheng plans to transfer 80% of Lu'an Ping'an Pharmacy Chain's shares for 105.6 million yuan
Gelonghui, March 27丨Chinese Health (301408.SZ) announced that in order to further increase penetration into the core market in Anhui Province, consolidate its competitive position in the existing market, and expand and improve the marketing network, the company's wholly-owned subsidiary, Anhui Guosheng Pharmacy Chain Co., Ltd. (“Anhui Guosheng” or “acquirer”) plans to purchase 80% of the shares of Shen Haibing, Gan Jihua, and Wang Sihua (hereinafter collectively referred to as the “counterparty”) (hereinafter collectively referred to as the “target company”) by paying cash “Deal” or “This time “Acquisitions”). Pricing for this deal
Is Anhui Huaren Health Pharmaceutical (SZSE:301408) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might
No Data